Malaria drugs touted by President Donald Trump as potential 'game changers' against COVID-19 are actually too dangerous for general use, the FDA has warned.
The agency also said that it's aware of a rise in outpatient prescriptions for the two drugs, and said that health care providers and patients need to be aware of the risks associated with the drugs.
"Hydroxychloroquine and chloroquine can cause abnormal heart rhythms such as QT interval prolongation and a dangerously rapid heart rate called ventricular tachycardia," the agency warned. , use of high-dose chloroquine by hospital patients with severe COVID-19 ended up leading to a much higher death rate.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. FDA warns against malaria drugs Trump championed for COVID-19The U.S. Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine in COVID-19 patients even as President Donald Trump, who has touted it as a 'game changer,' advocated for an additional review.
Read more »
FDA warns against malaria drug's COVID-19 use outside hospitalsThe U.S. Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine, touted by President Donald Trump, in COVID-19 patients outside of hospitals and clinical trials, citing risks of serious heart rhythm problems.
Read more »
FDA Issues Warning About Hydroxychloroquine for COVID-19As more attention focuses on hydroxychloroquine as a possible treatment for COVID-19, the FDA issues a warning about its inappropriate use
Read more »
The FDA just approved Columbia's Covid-19 plasma therapy study, backed by AmazonAmazon backed a study at Columbia University to help determine if it's safe and effective to give plasma collected from those who have recovered from the Covid-19 virus to other severely ill patients.
Read more »